Composition and methods for treatment of hiv infection

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/00 (2006.01) A61K 38/50 (2006.01)

Patent

CA 2346063

Method of inhibiting or treating Human Immunodeficiency Virus (HIV) infection, comprising administering to a patient in need thereof an effective amount of a pharmaceutically acceptable composition comprising a PEG-ASNase compound or asparaginase, and optionally at least one compound selected from the group consisting of protease inhibitor compounds, ribonucleotide reductase inhibitor compounds and HIV reverse transcriptase inhibitor compounds.

La présente invention concerne un procédé d'inhibition ou de traitement de l'infection par le Virus d'Immunodéficience Humaine (VIH), comprenant l'administration à un patient qui en a besoin d'une quantité efficace d'un point de vue thérapeutique d'asparaginase ou de l'un de ses sels pharmaceutiquement acceptables, et éventuellement d'au moins un composé choisi parmi le groupe comprenant les composés inhibiteurs de protéase, les composés inhibiteurs de ribonucléotide réductase et les composés inhibiteurs de transcriptase inverse du VIH ou l'un de leurs sels pharmaceutiquement acceptables.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Composition and methods for treatment of hiv infection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition and methods for treatment of hiv infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and methods for treatment of hiv infection will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1995832

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.